Impact of Smoking on Response to the First-Line Treatment of Advanced ALK-Positive Non-Small Cell Lung Cancer: A Bayesian Network Meta-Analysis

Impact of Smoking on Response to the First-Line Treatment of Advanced ALK-Positive Non-Small Cell Lung Cancer: A Bayesian Network Meta-Analysis

Background: The impact of smoking on the efficacy of anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) treatment is controversial and has not been systematically explored in the first-line setting. We performed a systematic review based on a pairwise meta-analysis and a Ba...

Full description

Bibliographic Details
Main Authors: Kehai Lin, Jie Lin, Zhong Huang, Jiding Fu, Qi Yi, Jiazuo Cai, Muhammad Khan, Yawei Yuan, Junguo Bu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Pharmacology
Subjects:
non-small cell lung cancer
anaplastic lymphoma kinase
tyrosine kinase inhibitors
smoking
progression-free survival
network meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.881493/full

Similar Items

Similar Items